BAJAJ BROKING

Notification
No new Notification messages
One Mobikwik Systems IPO is Open!
Apply for the One Mobikwik Systems IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
piramal pharma limited stock

PIRAMAL PHARMA LIMITED Share Price

258.35 -0.64 (-0.24%)
Dec 11 2024 03:30 PM Pharmaceuticals NSE: PPLPHARMA

PIRAMAL PHARMA LIMITED Share Price Update

As of the latest trading session, PIRAMAL PHARMA LIMITED share price is currently at 258.35, which is down by -0.64 from its previous closing. Today, the stock has fluctuated between 254.00 and 260.90. Over the past year, PIRAMAL PHARMA LIMITED has achieved a return of 103.29 %. In the last month alone, the return has been -3.96 %. Read More...

PIRAMAL PHARMA LIMITED Performance

Day Range

Low254.00 High260.90
258.35

52 Week Range

Low 114.35 High 307.90
258.35

PIRAMAL PHARMA LIMITED Share Price

11571

543635

PPLPHARMA

img img img img
No Data Available

Open Price

259.00

Prev. Close

259.00

Volume (Shares)

3066950.00

Total traded value

7923.46

Upper Circuit

310.80

Lower Circuit

207.20

Note: The current prices & values are delayed, Login to your account for live updates.

PIRAMAL PHARMA LIMITED Fundamentals


(Standalone)

Market Cap (Cr) 34178.36
PE Ratio (TTM) 53.25
Book Value / Share 52.94
Beta 0.63
ROE 6.53%
EPS (TTM) 4.85
Dividend Yield 0.04%
Net Profit Qtr (Cr) 210.06

PIRAMAL PHARMA LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 1284.39
Operating Expense 1115.06
Net Profit 210.06
Net Profit Margin (%) 16.35
Earnings Per Share (EPS) 1.59
EBITDA 359.27
Effective Tax Rate (%) 23.81
Particulars JUN 2024 (Values in Cr)
Revenue 1063.20
Operating Expense 988.30
Net Profit 85.27
Net Profit Margin (%) 8.02
Earnings Per Share (EPS) 0.64
EBITDA 188.39
Effective Tax Rate (%) 23.63
Particulars MAR 2024 (Values in Cr)
Revenue 1525.30
Operating Expense 1215.82
Net Profit 273.08
Net Profit Margin (%) 17.90
Earnings Per Share (EPS) 2.06
EBITDA 442.83
Effective Tax Rate (%) 24.70
Particulars DEC 2023 (Values in Cr)
Revenue 1024.14
Operating Expense 967.58
Net Profit 74.34
Net Profit Margin (%) 7.25
Earnings Per Share (EPS) 0.56
EBITDA 158.64
Effective Tax Rate (%) 17.08
Particulars SEP 2023 (Values in Cr)
Revenue 994.24
Operating Expense 987.13
Net Profit 77.16
Net Profit Margin (%) 7.76
Earnings Per Share (EPS) 0.61
EBITDA 175.24
Effective Tax Rate (%) 19.78
Particulars MAR 2024 (Values in Cr)
Revenue 4390.11
Operating Expense 4084.54
Net Profit 391.22
Net Profit Margin (%) 8.91
Earnings Per Share (EPS) 3.05
EBITDA 819.98
Effective Tax Rate (%) 22.93
Particulars MAR 2023 (Values in Cr)
Revenue 3443.22
Operating Expense 3653.64
Net Profit 69.50
Net Profit Margin (%) 2.01
Earnings Per Share (EPS) 0.58
EBITDA 431.64
Effective Tax Rate (%) 43.81
Particulars MAR 2022 (Values in Cr)
Revenue 3340.42
Operating Expense 3087.80
Net Profit 367.54
Net Profit Margin (%) 11.00
Earnings Per Share (EPS) 3.12
EBITDA 684.99
Effective Tax Rate (%) 20.50
Particulars MAR 2024 (Values in Cr)
Book Value / Share 59.80
ROE % 0.22
ROCE % 5.40
Total Debt to Total Equity 0.70
EBITDA Margin 17.47
Particulars MAR 2023 (Values in Cr)
Book Value / Share 56.76
ROE % -2.77
ROCE % 1.90
Total Debt to Total Equity 0.72
EBITDA Margin 12.72
Particulars MAR 2022 (Values in Cr)
Book Value / Share 56.47
ROE % 6.11
ROCE % 6.91
Total Debt to Total Equity 0.58
EBITDA Margin 19.35
Particulars MAR 2021 (Values in Cr)
Book Value / Share 56.35
ROE % 14.90
ROCE % 12.67
Total Debt to Total Equity 0.54
EBITDA Margin 26.25
Particulars MAR 2024 (Values in Cr)
Book Value / Share 50.74
ROE % 6.53
ROCE % 8.27
Total Debt to Total Equity 0.24
EBITDA Margin 18.68
Particulars MAR 2023 (Values in Cr)
Book Value / Share 44.09
ROE % 1.34
ROCE % 3.62
Total Debt to Total Equity 0.27
EBITDA Margin 12.54
Particulars MAR 2022 (Values in Cr)
Book Value / Share 43.20
ROE % 7.97
ROCE % 9.82
Total Debt to Total Equity 0.15
EBITDA Margin 20.51
Particulars MAR 2021 (Values in Cr)
Book Value / Share 41.23
ROE % 13.94
ROCE % 16.15
Total Debt to Total Equity 0.04
EBITDA Margin 28.42
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 482.56
Total Assets 15311.81
Total Liabilities 15311.81
Total Equity 7911.37
Share Outstanding 1322948130
Price to Book Ratio 2.54
Return on Assets (%) 0.11
Return on Capital (%) 0.14
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 307.56
Total Assets 14522.56
Total Liabilities 14522.56
Total Equity 6773.50
Share Outstanding 1193318500
Price to Book Ratio 1.55
Return on Assets (%) -1.28
Return on Capital (%) -1.52
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 328.99
Total Assets 12797.04
Total Liabilities 12797.04
Total Equity 6696.60
Share Outstanding 1185913506
Price to Book Ratio 0.00
Return on Assets (%) 2.93
Return on Capital (%) 3.51
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 405.62
Total Assets 10899.78
Total Liabilities 10899.78
Total Equity 5605.00
Share Outstanding 994600000
Price to Book Ratio 0.00
Return on Assets (%) 7.66
Return on Capital (%) 9.81
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 241.73
Total Assets 9550.88
Total Liabilities 9550.88
Total Equity 6712.07
Share Outstanding 1322948130
Price to Book Ratio 2.54
Return on Assets (%) 4.09
Return on Capital (%) 4.97
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 64.16
Total Assets 8042.40
Total Liabilities 8042.40
Total Equity 5261.79
Share Outstanding 1193318500
Price to Book Ratio 1.55
Return on Assets (%) 0.86
Return on Capital (%) 1.01
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 137.23
Total Assets 7371.04
Total Liabilities 7371.04
Total Equity 5123.12
Share Outstanding 1185913506
Price to Book Ratio 0.00
Return on Assets (%) 4.98
Return on Capital (%) 5.86
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 152.35
Total Assets 5756.67
Total Liabilities 5756.67
Total Equity 4100.62
Share Outstanding 994600000
Price to Book Ratio 0.00
Return on Assets (%) 9.92
Return on Capital (%) 13.4
Particulars MAR 2024 (Values in Cr)
Net Income 119.80
Cash from Operations 1161.38
Cash from Investing -434.01
Cash from Financing -422.36
Net change in Cash 148.17
Free Cash Flow 1873.42
Particulars MAR 2023 (Values in Cr)
Net Income -160.56
Cash from Operations 672.89
Cash from Investing -1338.78
Cash from Financing 817.79
Net change in Cash -37.10
Free Cash Flow 1637.63
Particulars MAR 2022 (Values in Cr)
Net Income 441.03
Cash from Operations 935.84
Cash from Investing -1812.10
Cash from Financing 794.19
Net change in Cash -251.49
Free Cash Flow 1825.35
Particulars MAR 2021 (Values in Cr)
Net Income 639.68
Cash from Operations 742.09
Cash from Investing -4479.93
Cash from Financing 3976.83
Net change in Cash 94.48
Free Cash Flow 1344.28
Particulars MAR 2024 (Values in Cr)
Net Income 507.62
Cash from Operations 436.10
Cash from Investing -635.52
Cash from Financing 451.38
Net change in Cash 174.15
Free Cash Flow 761.66
Particulars MAR 2023 (Values in Cr)
Net Income 123.69
Cash from Operations 131.55
Cash from Investing -435.05
Cash from Financing 290.12
Net change in Cash -73.41
Free Cash Flow 376.41
Particulars MAR 2022 (Values in Cr)
Net Income 477.41
Cash from Operations 351.85
Cash from Investing -1245.61
Cash from Financing 896.40
Net change in Cash -100.02
Free Cash Flow 584.67
Particulars MAR 2021 (Values in Cr)
Net Income 349.11
Cash from Operations 130.01
Cash from Investing -4382.89
Cash from Financing 4494.16
Net change in Cash 145.99
Free Cash Flow 188.12
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.90 37.87 3.59 505.01 37.54 / 77.70
BLISS GVS PHARMA LTD 155.50 19.46 1.62 1637.91 92.25 / 172.40
CIPLA LTD 1455.65 25.47 4.14 117560.12 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 414.95 144.08 4.20 1221.24 145.00 / 440.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.90 57.30 11.20 505.01 37.54 / 77.70
AMRUTAJAN HEALTH LTD 753.60 45.84 7.31 2178.71 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6634.15 128.84 24.41 16585.38 4050.15 / 8139.85
BLISS GVS PHARMA LTD 155.50 20.27 1.59 1637.91 92.25 / 172.40

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 262.60
  • 26 Days 262.80
  • 10 Days 261.10
  • 50 Days 251.40
  • 12 Days 260.60
  • 100 Days 226.60
  • 20 Days 263.10
  • 200 Days 143.50
257.58
PIVOT
First Resistance 265.12
Second Resistance 271.23
Third Resistance 278.77
First Support 251.47
Second Support 243.93
Third Support 237.82
RSI 50.76
MACD -2.14
Commodity Channel Index (CCI) -15.14
ADX 18.10
Williams % R -63.85

Over 1 Month

down

-3.96

Over 3 Months

down

11.90

Over 6 Months

down

64.81

Over 1 Year

down

103.29

Over 3 Years

down

11.75

Over 5 Years

down

0.00

PIRAMAL PHARMA LIMITED Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

PIRAMAL PHARMA LIMITED Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
19.51
Promoter Holdings
34.94
FII
31.73
DII
13.8
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
The Sri Krishna Trust Through Its Trustee Mr. Ajay G Piramal And Dr. (mrs.) Swati A Piramal Shareholding of Promoter and Promoter Group 3.5289142E8 26.62
Ca Alchemy Investments Public Shareholding 2.386637E8 18.0
Hdfc Trustee Company Limited-hdfc Flexi Cap Fund Public Shareholding 9.4477019E7 7.13
East Bridge Capital Master Fund I Ltd Public Shareholding 4.3410142E7 3.27
V3 Designs Llp Shareholding of Promoter and Promoter Group 4.3021826E7 3.25
Prl Realtors Llp Shareholding of Promoter and Promoter Group 3.9797353E7 3.0
Life Insurance Corporation Of India Public Shareholding 2.1473488E7 1.62
Indiahold Limited Public Shareholding 1.7299744E7 1.3
Piramal Welfare Trust (formerly Known As The Piramal Enterprise Executives Trust) Shareholding of Promoter and Promoter Group 1.0573898E7 0.8
Aasan Corporate Solutions Pvt. Ltd Shareholding of Promoter and Promoter Group 8931097.0 0.67
The Ajay G. Piramal Foundation Shareholding of Promoter and Promoter Group 4375937.0 0.33
Mr. Anand Piramal Shareholding of Promoter and Promoter Group 874082.0 0.07
Anand Piramal Trust Shareholding of Promoter and Promoter Group 617884.0 0.05
Nandini Piramal Trust Shareholding of Promoter and Promoter Group 544325.0 0.04
Mr. Ajay G. Piramal Shareholding of Promoter and Promoter Group 547326.0 0.04
Mr. Peter Deyoung Shareholding of Promoter and Promoter Group 432000.0 0.03
Ms. Nandini Piramal Shareholding of Promoter and Promoter Group 290418.0 0.02
Master Dev Piramal Deyoung Shareholding of Promoter and Promoter Group 192000.0 0.01
Ms. Anya Piramal Deyoung Shareholding of Promoter and Promoter Group 192000.0 0.01
The Hongkong And Shanghai Banking Corp.ltd. Public Shareholding 1332.0 0.0
Prl Agastya Buildcon Pvt. Ltd Shareholding of Promoter and Promoter Group 0.0 0.0
Topzone Mercantile Company Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Nithyam Realty Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
India Resurgence Arc Pvt. Ltd. Shareholding of Promoter and Promoter Group 0.0 0.0
India Resurgence Asset Management Business Pvt. Ltd. Shareholding of Promoter and Promoter Group 0.0 0.0
Piramal Trusteeship Services Pvt. Ltd. Shareholding of Promoter and Promoter Group 0.0 0.0
Piramal Sons Pvt. Ltd. Shareholding of Promoter and Promoter Group 0.0 0.0
The Gulita Trust Shareholding of Promoter and Promoter Group 0.0 0.0
Swati Piramal Trust Shareholding of Promoter and Promoter Group 0.0 0.0
Sreekovil Realty Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Anutham Realty Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Piramal Corporate & Management Services Pvt. Ltd. Shareholding of Promoter and Promoter Group 0.0 0.0
Mr. Ajay G. Piramal (karta Of Ajay G. Piramal Huf) Shareholding of Promoter and Promoter Group 28857.0 0.0
Mrs. Lalita G. Piramal Shareholding of Promoter and Promoter Group 4936.0 0.0
Dr. (mrs.) Swati A. Piramal Shareholding of Promoter and Promoter Group 9313.0 0.0
The Swastik Safe Deposit & Investments Ltd. Shareholding of Promoter and Promoter Group 0.0 0.0
The Sri Hari Trust Shareholding of Promoter and Promoter Group 0.0 0.0
The Sri Govinda Trust Shareholding of Promoter and Promoter Group 0.0 0.0
The Sri Gopikrishna Trust Shareholding of Promoter and Promoter Group 0.0 0.0
The Piramal Art Foundation Shareholding of Promoter and Promoter Group 0.0 0.0
Propiedades Realties Pvt. Ltd. Shareholding of Promoter and Promoter Group 0.0 0.0
Prl Properties Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Prl Infraconstructions & Developers Pvt. Ltd. Shareholding of Promoter and Promoter Group 0.0 0.0
Prl Developers Pvt. Ltd. Shareholding of Promoter and Promoter Group 0.0 0.0
Piramal Agastya Offices Private Limited(formerly Known As Prl Agastya Pvt. Ltd.) Shareholding of Promoter and Promoter Group 0.0 0.0
Piramal Water Pvt. Ltd. Shareholding of Promoter and Promoter Group 0.0 0.0
Piramal Realty & Developers Pvt. Ltd. (formerly Known As Piramal Urban Transport Network Pvt Ltd) Shareholding of Promoter and Promoter Group 0.0 0.0
Piramal Udgam Data Management Solutions Shareholding of Promoter and Promoter Group 0.0 0.0
Piramal Systems & Technologies Pvt. Ltd. Shareholding of Promoter and Promoter Group 0.0 0.0
Piramal Retail Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Piramal Residences Pvt. Ltd. Shareholding of Promoter and Promoter Group 0.0 0.0
Prpl Enterprises Pvt. Ltd (formerly Known As Piramal Realty Pvt. Ltd.) Shareholding of Promoter and Promoter Group 0.0 0.0
Piramal Natural Resources Pvt. Ltd. Shareholding of Promoter and Promoter Group 0.0 0.0
Piramal Metals Pvt. Ltd. Shareholding of Promoter and Promoter Group 0.0 0.0
Piramal Investment Advisory Services Pvt. Ltd. Shareholding of Promoter and Promoter Group 0.0 0.0
Piramal International Consultants Pvt. Ltd. Shareholding of Promoter and Promoter Group 0.0 0.0
Piramal Foundation Shareholding of Promoter and Promoter Group 0.0 0.0
Piramal Glass Pvt. Ltd. Shareholding of Promoter and Promoter Group 0.0 0.0
Piramal Fund Management Pvt. Ltd. Shareholding of Promoter and Promoter Group 0.0 0.0
Piramal Foundation For Education Leadership Shareholding of Promoter and Promoter Group 0.0 0.0
Piramal Estates Pvt. Ltd. Shareholding of Promoter and Promoter Group 0.0 0.0
Piramal Corporate Tower Private Limited (formerly Known As Piramal Consumer Products Pvt. Ltd.) Shareholding of Promoter and Promoter Group 0.0 0.0
Piramal Commercial Estates Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Piramal Homes Pvt. Ltd. (formerly Piramal Building Material And Cement Pvt. Ltd.) Shareholding of Promoter and Promoter Group 0.0 0.0
Piramal Biotech Pvt. Ltd. Shareholding of Promoter and Promoter Group 0.0 0.0
Piramal Enterprises Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Pel Management Sevices Pvt. Ltd. Shareholding of Promoter and Promoter Group 0.0 0.0
Pel Finhold Pvt. Ltd. Shareholding of Promoter and Promoter Group 0.0 0.0
Pdl Realty Pvt. Ltd. Shareholding of Promoter and Promoter Group 0.0 0.0
Pce Developers Pvt. Ltd. Shareholding of Promoter and Promoter Group 0.0 0.0
Nival Developers Pvt. Ltd. Shareholding of Promoter and Promoter Group 0.0 0.0
Piramal Corporate Services Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Montane Ventures Pvt. Ltd. Shareholding of Promoter and Promoter Group 0.0 0.0
Kaivalya Education Foundation Shareholding of Promoter and Promoter Group 0.0 0.0
Indiaventure Advisors Pvt. Ltd. Shareholding of Promoter and Promoter Group 0.0 0.0
Glider Buildcon Realtors Pvt. Ltd. Shareholding of Promoter and Promoter Group 0.0 0.0
Alpex Infraconstructions Pvt. Ltd. Shareholding of Promoter and Promoter Group 0.0 0.0

PIRAMAL PHARMA LIMITED

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Piramal Pharma Share Result Highlights

ParticularsSep 2024 (₹ Cr)Jun 2024 (₹ Cr)Mar 2024 (₹ Cr)Dec 2023 (₹ Cr)Sep 2023 (₹ Cr)
Revenue1284.391063.201525.301024.14994.24
Operating Expense1115.06988.301215.82967.58987.13
Net Profit210.0685.27273.0874.3477.16
Net Profit Margin (%)16.358.0217.907.257.76
Earnings Per Share (EPS)1.590.642.060.560.61
EBITDA359.27188.39442.83158.64175.24
Effective Tax Rate (%)23.8123.6324.7017.0819.78

Key Highlights:

  • Revenue increased to ₹1284.39 Cr in Sep 2024, significantly higher than ₹1063.20 Cr in Jun 2024.
  • Net Profit saw a sharp rise to ₹210.06 Cr in Sep 2024, compared to ₹85.27 Cr in Jun 2024, showing substantial growth.
  • Net Profit Margin improved to 16.35% in Sep 2024, reflecting better profitability compared to 8.02% in Jun 2024.
  • Earnings Per Share (EPS) rose to ₹1.59 in Sep 2024, a strong improvement over ₹0.64 in Jun 2024.
  • EBITDA was ₹359.27 Cr in Sep 2024, indicating a strong operational performance.

Piramal Pharma Share Annual Reports

ParticularsValue (₹ Cr)
Revenue4390.11
Operating Expense4084.54
Net Profit391.22
Net Profit Margin (%)8.91
Earnings Per Share (EPS)3.05
EBITDA819.98
Effective Tax Rate (%)22.93

Key Highlights:

  • Revenue of ₹4390.11 crore.
  • Operating expense of ₹4084.54 crore.
  • Net profit of ₹391.22 crore.
  • Net profit margin at 8.91%.
  • EPS of ₹3.05.
  • EBITDA of ₹819.98 crore.
  • Effective tax rate of 22.93%.
  • Piramal Pharma share price increased by 117.43% in the past year.

Piramal Pharma Share Dividend

ParticularsValue
Dividend Yield0.04%
Earnings Per Share (EPS)₹3.05
Net Profit₹391.22 Cr
Piramal Pharma Share Price₹273.45

Key Highlights:

  • Dividend yield of 0.04%.
  • EPS of ₹3.05.
  • Net profit of ₹391.22 crore.
  • Piramal Pharma share price at ₹273.45.

About PIRAMAL PHARMA LIMITED

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by PIRAMAL PHARMA LIMITED

Learn More About Stocks

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Piramal Pharma Ltd?

Answer Field

The share price of Piramal Pharma Ltd for NSE is ₹ 258.35 and for BSE is ₹ 258.25.

What is the Market Cap of Piramal Pharma Ltd?

Answer Field

The market cap of Piramal Pharma Ltd for NSE is ₹ 3,41,78.36 Cr. and for BSE is ₹ 3,41,65.14 Cr. as of now.

What is the 52 Week High and Low of Piramal Pharma Ltd?

Answer Field

The 52 Week High and Low of Piramal Pharma Ltd for NSE is ₹ 307.90 and ₹ 114.35 and for BSE is ₹ 307.85 and ₹ 114.45.

How to Buy Piramal Pharma Ltd share?

Answer Field

You can trade in Piramal Pharma Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Piramal Pharma Ltd?

Answer Field

The 1 year returns on the stock has been 103.29%.

What is the Current Share Price of Piramal Pharma Ltd?

Answer Field

Piramal Pharma Ltd share price is for NSE ₹ 258.35 & for BSE ₹ 258.25 as on Dec 11 2024 03:30 PM.

What is the Market Cap of Piramal Pharma Ltd Share?

Answer Field

The market cap of Piramal Pharma Ltd for NSE ₹ 3,41,78.36 & for BSE ₹ 3,41,65.14 as on Dec 11 2024 03:30 PM.

What is the P/E Ratio of Piramal Pharma Ltd Share?

Answer Field

As on Dec 11 2024 03:30 PM the price-to-earnings (PE) ratio for Piramal Pharma Ltd share is 53.25.

What is the PB ratio of Piramal Pharma Ltd Share?

Answer Field

As on Dec 11 2024 03:30 PM, the price-to-book (PB) ratio for Piramal Pharma Ltd share is 52.94.

How to Buy Piramal Pharma Ltd Share?

Answer Field

You can trade in Piramal Pharma Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Piramal Pharma Ltd Share on Bajaj Broking App?

Answer Field

To buy Piramal Pharma Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Piramal Pharma Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Popular FAQs

1. Who is the CEO of Piramal Pharma Ltd?

The CEO of Piramal Pharma Ltd is Nandini Piramal. She is also the Chairperson of Piramal Enterprises Ltd, which is the parent company of Piramal Pharma Ltd. Under her leadership, the company has expanded its offerings in the pharmaceutical sector, including drug discovery, development, and manufacturing services.

 

2. When was Piramal Pharma Ltd established?

Piramal Pharma Ltd was incorporated on March 4, 2020, as a public limited company. The company was subsequently registered with the Registrar of Companies (RoC). It came into existence as a part of Piramal Enterprises Ltd's strategic reorganisation, which aimed to demerge its pharmaceutical business and expand its capabilities in drug manufacturing, biologics, vaccines, and self-care products.

 

3. What factors influence the Piramal Pharma Share Price?

The Piramal Pharma share price is influenced by various factors, including the company’s financial performance, industry growth, and global demand for pharmaceutical products. Key drivers include the company’s expansion into biologics and vaccines, joint ventures with companies like Allergan (now AbbVie), and the launch of new products. Other factors such as regulatory changes, competition in the pharmaceutical industry, and global market conditions also impact the Piramal Pharma share price.

 

4. Is Piramal Pharma Ltd debt-free?

No, Piramal Pharma Ltd is not debt-free. The company has undertaken strategic acquisitions and investments, which sometimes involve debt financing. However, Piramal Pharma has a strong portfolio of differentiated products and services, a global manufacturing footprint, and an expanding distribution network that support its ability to manage and service its debt.

 

5. What is the CAGR of Piramal Pharma Share?

The Compound Annual Growth Rate (CAGR) of the Piramal Pharma share price is not readily available for 10 years and 5 years. However, the share price has performed well over the past year, with a notable increase of 117%. This growth is indicative of the company’s positive trajectory, particularly following the demerger from Piramal Enterprises Ltd and its strategic investments and acquisitions.

 

6. How has the Piramal Pharma Share Price performed over the past year?

The Piramal Pharma share price has performed exceptionally well over the past year, with a significant increase of 117%. This growth can be attributed to the company's strategic initiatives, including the expansion of its product offerings, the successful demerger from Piramal Enterprises, and its continued expansion into high-demand sectors such as biologics and vaccines. The company has also strengthened its global presence, which has positively impacted investor confidence and share price performance.

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader